# GeneOne Life Science signs $2.3M plasmid DNA supply contract

GeneOne Life Science announced a $2.3 million contract to supply plasmid DNA pharmaceuticals to an undisclosed U.S. gene therapy company.

- Type: Contract
- Announced: 2020-12-18
- Value: $2.30M
- Status: announced
- Products: plasmid DNA pharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GeneOne Life Science](https://endata.com/companies/51997.md)

## Sources

- [asiae.co.kr](https://www.asiae.co.kr/en/article/2020121809320546210), 2020-12-18: "Every year, around 200 early-stage cell and gene therapy clinical trial applications (IND) are submitted to the U.S. FDA."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.